Literature DB >> 925694

Effect of nicergoline on cerebral blood flow.

L D Iliff, G H Du Boulay, J Marshall, R W Russell, L Symon.   

Abstract

Cerebral blood flow (CBF) was measured before and after intravenous injection of the cerebral vasodilator nicergoline in 13 patients with cerebrovascular disease. CBF increased in seven. The possibility that the effect of the drug in the remainder may have been masked by a fall of CBF which occurs during sequential measurement of patients at rest is discussed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 925694      PMCID： PMC492828          DOI： 10.1136/jnnp.40.8.746

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  5 in total

1.  Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe.

Authors:  J Olesen; O B Paulson; N A Lassen
Journal:  Stroke       Date:  1971 Nov-Dec       Impact factor: 7.914

2.  Regional blood flow in the normal cerebral hemisphere.

Authors:  I M Wilkinson; J W Bull; G H Duboulay; J Marshall; R W Russell; L Symon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-10       Impact factor: 10.154

3.  Vasodilating and alpha-receptor blocking activity of a new ergoline derivative.

Authors:  G Arcari; L Dorigotti; G B Fregnan; A H Glässer
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

4.  Action of lysergide, ephedrine, and nimergoline on brain metabolizing activity.

Authors:  G Benzi; L Manzo; M De Bernardi; A Ferrara; L Sanguinetti; E Arrigoni; F Berté
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

5.  Variations in mean cerebral blood flow under anesthesia at rest and during cortical activation.

Authors:  N I Palmer; D J Thomas; B B MacGillivray; G H Du Boulay; J Marshall; R R Russell; L Symon
Journal:  Stroke       Date:  1977 Mar-Apr       Impact factor: 7.914
  5 in total
  7 in total

1.  Biosynthesis of the Pharmaceutically Important Fungal Ergot Alkaloid Dihydrolysergic Acid Requires a Specialized Allele of cloA.

Authors:  Stephanie L Arnold; Daniel G Panaccione
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

2.  Effect of tinofedrine (Homburg D8955) on cerebral blood flow in multi-infarct dementia.

Authors:  J Merory; G H Du Boulay; J Marshall; J Morris; R W Russell; L Symon; D J Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-10       Impact factor: 10.154

3.  Genetic Reprogramming of the Ergot Alkaloid Pathway of Metarhizium brunneum.

Authors:  Kyle A Davis; Jessi K Sampson; Daniel G Panaccione
Journal:  Appl Environ Microbiol       Date:  2020-09-17       Impact factor: 4.792

4.  Ergot alkaloids contribute to virulence in an insect model of invasive aspergillosis.

Authors:  Daniel G Panaccione; Stephanie L Arnold
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 5.  Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.

Authors:  Matěj Malík; Pavel Tlustoš
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

Review 6.  Therapeutic use of nicergoline.

Authors:  Bengt Winblad; Mario Fioravanti; Tomas Dolezal; Inara Logina; Ivan Gospodinov Milanov; Dinu Cristian Popescu; Alina Solomon
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580

Review 7.  Safety of nicergoline as an agent for management of cognitive function disorders.

Authors:  Bernd Saletu; Amit Garg; Ahsan Shoeb
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.